vimarsana.com

பூங்கா ஊழியர் வருடாந்திரம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Park Employees Annuity and Benefit Fund of Chicago (Park Employees Annuity and Benefit Fund of Chicago) - Public Pension, United States

Bleichmar Fonti Wants To Retake Lead In Endo Investor Suit

ADVERTISEMENT ADVERTISEMENT Bleichmar Fonti Wants To Retake Lead In Endo Investor Suit Law360 (February 19, 2021, 3:56 PM EST) A Chicago-based retirement fund and attorneys from Bleichmar Fonti & Auld asked a federal judge to reinstate them as leads in a stockholder class action against Endo Pharmaceuticals, arguing that the court erred in ruling that buying Endo stock 97 seconds after news broke of an alleged price-fixing scheme had raised issues disqualifying them. Bleichmar Fonti and the Park Employees Annuity and Benefit Fund of Chicago claimed that they had not acted improperly or deceived the court about the timing of the stock purchase or the records they had of it, maintaining that the buy was initiated before the first news.

Lead Plaintiff Booted From Endo Suit Over 97-Second Lag

ADVERTISEMENT ADVERTISEMENT Lead Plaintiff Booted From Endo Suit Over 97-Second Lag Law360 (February 5, 2021, 9:48 PM EST) Bleichmar Fonti & Auld LLP is out as lead plaintiffs counsel in an Endo Pharmaceuticals stockholder class action, replaced by Saxton & Stump LLC, after a Pennsylvania federal judge found out that the previous lead plaintiff bought shares 97 seconds after news broke of the alleged price-fixing scheme. U.S. District Judge Michael M. Baylson said Thursday that the Park Employees Annuity and Benefit Fund of Chicago and Bleichmar Fonti had for months maintained that they had no idea and no way of knowing whether the fund s purchase of Endo stock in November 2016 came before or after media reports first hinting.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.